ELIOS

What ELIOS does

Elios Vision, Inc. is a privately held medical technology company that has developed the ELIOS system, an excimer-laser-based platform for minimally invasive glaucoma surgery (MIGS). The device uses high-precision, non-thermal laser ablation to create ten microchannels in the trabecular meshwork, enhancing physiological aqueous outflow into Schlemm's canal while preserving angle anatomy and avoiding implant placement. ELIOS is positioned as the first clinically-validated excimer-laser MIGS procedure, with reported outcomes including IOP reduction sustained out to eight years, up to 80% of patients medication-free at one year, and demonstrated microchannel patency at 31 months.

The company is incorporated in California and operates a German distribution subsidiary, Elios Vision GmbH, based in Germering, which serves as the EU distributor for the ELIOS console manufactured by MLase GmbH and the FIDO laser applicator manufactured by WEINERT Fiber Optics GmbH. The product is CE marked and commercially available in the EU for adult glaucoma patients, while in the United States it remains limited to investigational use under an ongoing FDA IDE study at participating clinical sites. Marketing and education are directed at ophthalmologists, glaucoma specialists, and cataract surgeons through a multilingual digital presence (DE, EN-OUS, ES, FR, IT, PT), a resource library, a podcast series, and active social channels.

The business model is a medical-device capital-plus-consumable sale: the laser console is placed with surgical centers and the FIDO applicator generates procedure-level revenue. The primary use case is implant-free glaucoma treatment performed concurrently with cataract surgery, addressing the sizable population of patients with co-existing cataract and mild-to-moderate glaucoma. Pricing is not publicly disclosed and no revenue, funding, or headcount figures are available, so commercial scale cannot be quantified from the source material.

Name

ELIOS

Legal name

Elios Vision, Inc.

Website

https://eliosvision.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Elios Vision is a medical device company that markets the ELIOS excimer-laser MIGS system for implant-free glaucoma treatment, distributed in the EU by its German subsidiary and under FDA IDE investigation in the US, serving ophthalmologists and cataract surgeons.

Ownership category

akta.pro rank

Product category

Ophthalmic Medical Devices

NAICS

Ophthalmic Goods Manufacturing (339115)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Glaucoma Diagnostics & Surgical Devices (Tonometry, Gonioscopy, MIGS, Drainage Implants, Laser Trabeculoplasty) (HLAHAJAI)

akta.pro secondary industry

Glaucoma Specialists (HLAKAKAG)

Keywords

• Minimally invasive glaucoma surgery
• Excimer laser devices
• Ophthalmic medical devices
• Intraocular pressure reduction
• Glaucoma treatment systems

Headquarters

HQ city

Los Angeles

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Operations, Marketing or Sales, Personnel, Infrastructure

Distribution channels2 records

Marketing channels5 records

Core offering

Elios Vision develops and distributes the ELIOS excimer laser system, an implant-free minimally invasive glaucoma surgery (MIGS) platform that uses high-precision, non-thermal laser ablation to create 10 microchannels in the trabecular meshwork to enhance physiological outflow into Schlemm's canal. The company also distributes the companion FIDO laser applicator, and its core use case is performing glaucoma treatment during cataract surgery as well as standalone procedures for patients with mild-to-moderate glaucoma.

Product overview

ELIOS Vision is a medical technology company that offers a single unified product system for glaucoma treatment. The core offering is the ELIOS excimer laser system, which performs minimally invasive glaucoma surgery (MIGS) by creating microchannels in the trabecular meshwork. The company also distributes the FIDO laser applicator manufactured by WEINERT Fiber Optics GmbH as part of the complete treatment system. ELIOS Vision GmbH serves as the EU distributor for products manufactured by MLase GmbH.

Differentiator

Problem solved

Functional benefit

Brands

• ELIOS: Next generation glaucoma treatment technology using high precision, non-thermal, laser ablation to create 10 microchannels in the trabecular meshwork.

Products and services

• ELIOS Excimer Laser MIGS System A next-generation excimer laser system for minimally invasive glaucoma surgery (MIGS) that uses high-precision, non-thermal laser ablation to create 10 microchannels in the trabecular meshwork to enhance physiological outflow into Schlemm's canal while preserving angle anatomy; used by ophthalmologists, glaucoma specialists, and cataract surgeons for standalone glaucoma treatment or combined cataract-glaucoma procedures in adult patients with mild-to-moderate glaucoma.
• FIDO Laser Applicator A laser applicator manufactured by WEINERT Fiber Optics GmbH for use with the ELIOS laser system in glaucoma treatment procedures; sold as part of the complete ELIOS treatment system to ophthalmologists and glaucoma specialists in the EU.

Quantifiable outcome

• IOP reduction (>20%) for up to 8 years
• +3 more outcomes

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• MLase GmbHcoreOEM/ Whitelabel/ Licensing PartnerMLase GmbH is the manufacturer of the ELIOS laser system. Located at 82110 Germering, Industriestr. 17, Germany. Elios Vision GmbH serves as the EU distributor for MLase-manufactured ELIOS products.
• WEINERT Fiber Optics GmbHcoreOEM/ Whitelabel/ Licensing PartnerWEINERT Fiber Optics GmbH manufactures the FIDO laser applicator used with the ELIOS system. Located at Mittlere-Motsch-Strasse 26, 96515 Sonneberg, Germany. The FIDO laser applicator is CE marked and included in the EU product distribution.

Recent moves5 records

Expansion highlights4 records

Emerging players

• BELKIN Vision Ltd. BELKIN Vision is developing the Eagle laser-based glaucoma treatment, a direct laser MIGS approach using a different laser modality. It represents an emerging peer in the laser MIGS sub-segment where ELIOS also competes.
• iSTAR Medical: iSTAR Medical develops the MINIject suprachoroidal MIGS implant. It addresses a different outflow pathway but competes for the same glaucoma patient population and ophthalmic surgeon customers as ELIOS.
• Nova Eye Medical: Nova Eye Medical markets the iTrack canal-based MIGS system and related glaucoma surgical devices. It competes in the ab-interno MIGS space with a mechanized microcatheter approach, sharing ELIOS's target surgeon base and mild-to-moderate glaucoma focus.

Direct peers

• Sight Sciences: Sight Sciences offers the OMNI surgical system, a MIGS device that addresses multiple pathways including trabecular meshwork. It targets the same mild-to-moderate glaucoma and combined-cataract patient population served by ELIOS.
• New World Medical: New World Medical markets the Kahook Dual Blade, a goniotomy-based MIGS device for ab-interno trabecular meshwork procedures. It is directly comparable to ELIOS as an implant-free option targeting ophthalmologists performing combined cataract and glaucoma surgery.
• Glaukos Corporation: Glaukos is the pioneer and market leader in MIGS with the iStent portfolio. ELIOS competes directly in the trabecular meshwork MIGS category and targets the same ophthalmologist and cataract surgery channels.

Others

• MLase GmbH: MLase GmbH is the OEM manufacturer of the ELIOS excimer laser console. It is a strategic upstream supplier and partner, not a direct competitor, but is closely tied to ELIOS's product availability and quality.
• WEINERT Fiber Optics GmbH: WEINERT Fiber Optics GmbH manufactures the FIDO laser applicator used with the ELIOS system. As a core OEM partner, it is materially relevant to ELIOS's product offering though it is a supplier rather than a direct market competitor.

Broad incumbents

• Alcon: Alcon is a global ophthalmic incumbent offering the Hydrus Microstent (acquired via Ivantis) alongside its cataract surgery franchise. It competes with ELIOS in MIGS and in the combined cataract+glaucoma procedure, while operating a far broader product portfolio.
• Lumibird (Ellex / Quantel Medical): Lumibird, through its Ellex and Quantel Medical legacy brands, offers laser systems used in ophthalmology including selective laser trabeculoplasty (SLT). It is adjacent to ELIOS as a broader laser-based glaucoma and ophthalmology equipment provider.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat3 records

Key risks2 records

Key highlights6 records

Customer concentration

• Xx.com/elios_vision
• Facebookfacebook.com/ELIOSVision
• LinkedInlinkedin.com/company/eliosvision
• Instagraminstagram.com/elios.vision

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ELIOS